A randomised, comparative, double-blind, parallel group, multi-centre Phase IIIa study to eradicate Helicobacter Pylori, heal gastric ulcer and prevent relapse in gastric ulcer subjects with esomeprazole in combination with amoxicillin and clarithromycin.
Study identifier:SH-NEH-0001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A randomised, comparative, double-blind, parallel group, multi-centre Phase IIIa study to eradicate Helicobacter Pylori, heal gastric ulcer and prevent relapse in gastric ulcer subjects with esomeprazole in combination with amoxicillin and clarithromycin.
Medical condition
gastrointestinal diseases
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Oct 2001
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
